From the National Center for Advancing Translational Sciences
From the National Institutes of Health
Emerging Molecular Markers in Uveal Melanoma and Implications for Treatment
Sunday, November 17, 2013
The goal is to establish a collaborative framework for future translational applications directed toward improved diagnosis, prognosis and therapy for individuals with UM. The expected outcome is to establish a set of specific research priorities for improved classification system for UM to promote stratification of patients for marker driven clinical trials in UM which will be followed-up with pilot concepts.
Contact: Dr. Magdalena Thurin (301) 496-1591
National Cancer Institute
Office of Rare Diseases Research